Genmab A/S
Genmab's GHG Emissions Data Preview
In 2023, Genmab completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Genmab has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Genmab's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Genmab amounted to 555 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Genmab increased by 40.93%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Genmab's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Genmab's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Genmab were 317 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Genmab reduced its Scope 1 emissions over time?
Since 2021, Genmab's Scope 1 emissions have decreased by 7.09%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Genmab's Scope 1 emissions increased by 11.97%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Genmab's Scope 2 emissions?
In 2023, Genmab reported Scope 2 greenhouse gas (GHG) emissions of 238 tCOâ‚‚e using the market-based method.
Has Genmab reduced its Scope 2 emissions over time?
Since 2021, Genmab's Scope 2 greenhouse gas (GHG) emissions (Market-Based) have decreased by 20%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Genmab's Scope 2 emissions (Market-Based) rose by 115% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Genmab use for Scope 2 reporting?
In 2023, Genmab reported its Scope 2 emissions using the market-based method.
Genmab's Scope 2 Emissions Over Time
- Total Scope 2 Market-Based